ArchiveMarch 2012

Alemtuzumab 5 year follow up

Coles AJ, et al. Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial.Neurology. 2012 Mar 21. [Epub ahead of print] OBJECTIVE: To report the long-term safety and efficacy results from CAMMS223 comparing alemtuzumab with interferon β-1a in early, active relapsing-remitting multiple sclerosis (RRMS). What are the long-term effects of alemtuzumab treatment...

Research: Use it or Lose It

Epub: Sumowski JF et al. Cognitive reserve in secondary progressive multiple sclerosis. Mult Scler 2012. Background: Consistent with the cognitive reserve hypothesis, lifetime intellectual enrichment protects MS patients from cognitive impairment. As studies have focused predominately on patients with relapsing-remitting courses, it is unknown whether lifetime enrichment is protective against...

Research: Outcome measures for constipation

Thiruppathy K, Roy A, Preziosi G, Pannicker J, Emmanuel A Morphological Abnormalities of the Recto-Anal Inhibitory Reflex Reflects Symptom Pattern in Neurogenic Bowel.Dig Dis Sci. 2012 Mar 18. [Epub ahead of print] BACKGROUND: Bowel dysfunction amongst multiple sclerosis (MS) and spinal cord injury (SCI) patients often manifests as fecal (pooh) incontinence (FI) or constipation, but the...

MS Mouse at MS life

MouseDocotor is getting ready for MS life on April 14th and 15th in “Manchester, England”. This is free to register and is the UKs biggest lifestyle event for MSers He has got his special lab coat in UK MS Society orange ready for “Meet the Scientists” when you will get the oppertunity to meet and talk with MS MouseDoc (back of lab coat in the inset) and his chums. You can...

Research: If you don’t understand, don’t be afraid to ask!

Winter MR, Fang C, Banker G, Roysam B, Cohen AR.Axonal transport analysis using Multitemporal Association Tracking. Int J Comput Biol Drug Des. 2012;5(1):35-48 Multitemporal Association Tracking (MAT) is a new graph-based method for multitarget tracking in biological applications that reduces the error rate and implementation complexity compared to approaches based on bipartite matching. The data...

Explaining the Problem of CCSVI Theory and Solution

Here is a recently posted video on the state of CCSVI. It tells you where you can get your updates on the “fact” or “fiction” of the procedure and the state of play on how people are attempting to disprove the hypothesis in randomised blinded trials………….. Yes this is the basis of the Scientific (Karl Popper) approach….You should try to...

Research: CCSVI monthly March

I know it is not quite the end of the month but whilst we are in an anonymous-free zone we might as well get these out of the way, but next week Prof G Down under is moving somewhere less contentious and giving you the veg, without the meat, of the Charcot Project. For this months CCSVI posts since last time we have, no doubt more next month. Simka M et al. Prevalence of extracranial venous...

Trolling Alert

Dear Rizzla2102 Please desist from trolling, you have made the post. It is on the blog (without the LINK).  Please stop posting the same comment over and over again. They are going to SPAM and staying there. It is very irritating for those recieving email alerts (I do not get them so you are not irritating me by your fellow bloggers). Likewise Dear Rich (rmforall) as I emailed you, we...

Research: Bones and Brains

Epub ahead of print: Batista et al. Cognitive impairment is associated with reduced bone mass in multiple sclerosis. Mult Scler. 2012 Mar 14.  Background: Multiple sclerosis (MS) has been associated with reduced bone mineral density (BMD), yet the underlying causes are not fully known. The recent discovery that bone homeostasis is directly regulated by the brain led us to hypothesize that it...

Translate

Categories

Recent Posts

Recent Comments

Archives